256 related articles for article (PubMed ID: 31894378)
1. Adrenal cortical carcinoma: pathology, genomics, prognosis, imaging features, and mimics with impact on management.
Ahmed AA; Thomas AJ; Ganeshan DM; Blair KJ; Lall C; Lee JT; Morshid AI; Habra MA; Elsayes KM
Abdom Radiol (NY); 2020 Apr; 45(4):945-963. PubMed ID: 31894378
[TBL] [Abstract][Full Text] [Related]
2. Surgical treatment of adrenal carcinoma.
Gaujoux S; Weinandt M; Bonnet S; Reslinger V; Bertherat J; Dousset B
J Visc Surg; 2017 Oct; 154(5):335-343. PubMed ID: 28754418
[TBL] [Abstract][Full Text] [Related]
3. Molecular Imaging in the Management of Adrenocortical Cancer: A Systematic Review.
Wong KK; Miller BS; Viglianti BL; Dwamena BA; Gauger PG; Cook GJ; Colletti PM; Rubello D; Gross MD
Clin Nucl Med; 2016 Aug; 41(8):e368-82. PubMed ID: 26825212
[TBL] [Abstract][Full Text] [Related]
4. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
[TBL] [Abstract][Full Text] [Related]
5. Adrenocortical carcinoma: review of the pathologic features, production of adrenal steroids, and molecular pathogenesis.
Nakamura Y; Yamazaki Y; Felizola SJ; Ise K; Morimoto R; Satoh F; Arai Y; Sasano H
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):399-410. PubMed ID: 26038208
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathology of adrenal cortical tumors: separating adenomas from carcinomas.
Giordano TJ
Endocr Pathol; 2006; 17(4):355-63. PubMed ID: 17525484
[TBL] [Abstract][Full Text] [Related]
7. Adrenocortical carcinoma.
Rodgers SE; Evans DB; Lee JE; Perrier ND
Surg Oncol Clin N Am; 2006 Jul; 15(3):535-53. PubMed ID: 16882496
[TBL] [Abstract][Full Text] [Related]
8. Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomography.
Werner RA; Kroiss M; Nakajo M; Mügge DO; Hahner S; Fassnacht M; Schirbel A; Bluemel C; Higuchi T; Papp L; Zsótér N; Buck AK; Bundschuh RA; Lapa C
Endocrine; 2016 Sep; 53(3):791-800. PubMed ID: 27138903
[TBL] [Abstract][Full Text] [Related]
9. [¹²³I]Iodometomidate imaging in adrenocortical carcinoma.
Kreissl MC; Schirbel A; Fassnacht M; Haenscheid H; Verburg FA; Bock S; Saeger W; Knoedler P; Reiners C; Buck AK; Allolio B; Hahner S
J Clin Endocrinol Metab; 2013 Jul; 98(7):2755-64. PubMed ID: 23609836
[TBL] [Abstract][Full Text] [Related]
10. Adrenocortical carcinoma: the range of appearances on CT and MRI.
Bharwani N; Rockall AG; Sahdev A; Gueorguiev M; Drake W; Grossman AB; Reznek RH
AJR Am J Roentgenol; 2011 Jun; 196(6):W706-14. PubMed ID: 21606258
[TBL] [Abstract][Full Text] [Related]
11. Clinical and histopathological evaluation of the adrenal incidentaloma.
Sworczak K; Babńiska A; Stanek A; Lewczuk A; Siekierska-Hellmann M; Błaut K; Drobińska A; Basiński A; Lachński AJ; Czaplińska-Kałas H; Gruca Z
Neoplasma; 2001; 48(3):221-6. PubMed ID: 11583293
[TBL] [Abstract][Full Text] [Related]
12. CT imaging characteristics of oncocytic adrenal neoplasms (OANs): comparison with adrenocortical carcinomas.
Khan M; Caoili EM; Davenport MS; Poznanski A; Francis IR; Giordano T; Dunnick NR
Abdom Imaging; 2014 Feb; 39(1):86-91. PubMed ID: 24271078
[TBL] [Abstract][Full Text] [Related]
13. Adrenocortical carcinoma: clinical and laboratory observations.
Wajchenberg BL; Albergaria Pereira MA; Medonca BB; Latronico AC; Campos Carneiro P; Alves VA; Zerbini MC; Liberman B; Carlos Gomes G; Kirschner MA
Cancer; 2000 Feb; 88(4):711-36. PubMed ID: 10679640
[TBL] [Abstract][Full Text] [Related]
14. Adrenocortical carcinoma with tumor thrombus in the right hepatic vein.
Reyes MA; Ciancio G; Singal R; Manoharan M
Int J Urol; 2006 Sep; 13(9):1233-5. PubMed ID: 16984559
[TBL] [Abstract][Full Text] [Related]
15. 1500 gram suprarenal mass: a case report.
Jones KM; Singh A; Haas GP; Landas SK
Can J Urol; 2007 Apr; 14(2):3518-22. PubMed ID: 17466160
[TBL] [Abstract][Full Text] [Related]
16. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M
Eur J Endocrinol; 2018 Oct; 179(4):G1-G46. PubMed ID: 30299884
[TBL] [Abstract][Full Text] [Related]
17. Preoperative 18F-FDG uptake is strongly correlated with malignancy, Weiss score, and molecular markers of aggressiveness in adrenal cortical tumors.
Gust L; Taieb D; Beliard A; Barlier A; Morange I; de Micco C; Henry JF; Sebag F
World J Surg; 2012 Jun; 36(6):1406-10. PubMed ID: 22131094
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Survival in a Patient With Metastatic DDR2-Positive Adrenal Cortical Carcinoma.
Taza F; Chovanec M; Hahn N; Albany C
Clin Genitourin Cancer; 2017 Oct; 15(5):e893-e895. PubMed ID: 28606737
[No Abstract] [Full Text] [Related]
19. The next step: mechanisms driving adrenocortical carcinoma metastasis.
Lalli E; Luconi M
Endocr Relat Cancer; 2018 Feb; 25(2):R31-R48. PubMed ID: 29142005
[TBL] [Abstract][Full Text] [Related]
20. The construction and analysis of tumor-infiltrating immune cells and ceRNA networks in metastatic adrenal cortical carcinoma.
Huang R; Liu Z; Tian T; Song D; Yan P; Yin H; Hu P; Zhu X; Liu Y; Li Z; Meng T; Zhang J; Huang Z
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32175564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
